Fibroblast Treatment Risks Explained: Pigment Changes, Scarring and Skin Types at Higher Risk

She had already saved the photo. A screenshot of an upper eyelid, taut and bright, with a grid of tiny brown dots fading into smooth skin. Underneath, a caption promised “no cutting, no downtime, natural results.” What the photo did not show was the same eyelid at week three, when the dots had healed into a pale, slightly shiny patch that no longer matched the skin around it.

That gap between the promise and the follow-up is where most conversations about fibroblast treatment risks should begin. A plasma pen does not pull skin tighter the way a surgeon’s suture does. It burns it, deliberately and in a pattern, and asks the body to heal in a way that shrinks the surface. Sometimes the body cooperates. Sometimes it overreacts, and the record of that reaction is written in pigment and scar.

This explainer walks through what actually happens under the device, why some skin tones are more vulnerable than others, what the days and weeks afterward usually look like, and which questions are worth asking before anyone touches your face.

What fibroblast treatment actually is, and what happens under the pen

The name is a piece of marketing that has stuck. A fibroblast is a skin cell that manufactures collagen, the protein scaffolding that keeps skin firm. The treatment does not inject or apply fibroblasts. It relies on a handheld device, usually called a plasma pen, that ionizes the air between its tip and the skin. Ionizing means stripping electrons from gas molecules so they carry a charge; the result is a tiny electrical arc that jumps to the skin and vaporizes a pinpoint of surface tissue.

Each arc leaves a small brown dot, typically a millimeter or less across, and the practitioner places dozens or hundreds of them in a grid across the target area: upper eyelids, crow’s feet, upper lip lines, neck creases, sometimes stretch marks or small skin tags. The heat does two things at once. It removes a fleck of epidermis, the outermost layer, and it causes the collagen fibers just beneath to contract, which is why the skin looks tighter immediately after treatment.

That instant tightening is partly heat shrinkage and partly swelling. The longer-term hope is that the wound-healing response lays down new collagen over the following weeks and months. This is the same broad principle behind ablative laser resurfacing, which the Mayo Clinic describes as removing thin layers of skin to stimulate new growth, though a plasma pen delivers far less controllable energy than a medical laser and is often used outside clinical settings.

Understanding this point matters because every risk that follows flows from it. A plasma pen is a burn tool with a fine tip. The dots are wounds. How your particular skin heals a wound decides whether the result is smoother skin, a spray of dark freckles, a pale map of the grid, or a scattering of small pitted scars.

Why fibroblast treatment risks come down to a controlled burn

Dermatologists classify thermal injuries by depth, and depth is exactly what a plasma pen struggles to standardize. The arc’s energy depends on the device’s power setting, how long the tip hovers, the distance from the skin, the moisture on the surface, and the steadiness of the operator’s hand. Two dots placed a centimeter apart can reach different depths. A practitioner who lingers a fraction of a second longer, or who overlaps dots to “make sure,” can push what should be a superficial epidermal wound down into the dermis, where scarring becomes possible.

Medical lasers used for resurfacing meter their energy per pulse and are usually operated under the supervision of physicians trained in wound depth. Plasma pens are marketed to a much wider group, including people with short certificate courses and no medical background, and the devices themselves vary enormously in quality. Some are sold directly to consumers for home use. None of this makes the technology inherently dangerous in expert hands, but it does mean the risk profile depends heavily on who is holding the pen and on what they know about skin.

Heat also spreads sideways. Even a well-placed dot warms a small halo of surrounding tissue. In lighter skin that halo usually heals invisibly. In skin with more active melanocytes, the pigment-producing cells, a heated halo can trigger excess melanin production, or damage those cells so they stop producing pigment altogether. The visible grid pattern that some patients describe months later, dark or pale dots in neat rows, is a direct portrait of that thermal spread.

None of these mechanisms are unique to fibroblast treatment. They are the same wound-healing behaviors seen after any deliberate skin injury. What is distinctive here is the combination of variable energy, variable training, and heavy promotion to people whose skin tones were rarely represented in the small studies that exist.

Post-inflammatory hyperpigmentation: the most common plasma pen side effect

Ask anyone who has worked in a skin clinic what worries them most after a plasma pen treatment, and dark patches usually come first. Post-inflammatory hyperpigmentation, often shortened to PIH, is the darkening that appears where skin has been inflamed or injured. The Cleveland Clinic describes it as a common response in which melanocytes release extra melanin during healing, leaving a brown, gray, or purplish stain that outlasts the original wound.

After fibroblast treatment, PIH tends to show up not in the first week, when the dots are simply crusted, but in weeks two to six, once the crusts have fallen away and fresh skin is exposed. The dots may look darker than the surrounding skin, or the whole treated field may take on a muddy tone. Sun exposure during this window makes things markedly worse, because ultraviolet light drives the same melanocytes harder.

How long it lasts is the question everyone asks. The honest answer is that it varies. The Cleveland Clinic notes that post-inflammatory hyperpigmentation can fade on its own over months, but that deeper or more extensive pigment may persist for a year or longer and sometimes needs treatment to improve. Prescription lightening agents exist and are sometimes used by dermatologists, but whether they are appropriate, and for how long, is a decision for a clinician who has examined the skin.

Two things make PIH more likely after a plasma pen than after many other procedures. The first is that heat, not just mechanical injury, is the trigger, and heat is a strong stimulus for melanin. The second is that eyelid and perioral skin, the areas most often treated, is thin and richly supplied with blood, so inflammation is brisk. Anyone who has ever had an acne spot leave a dark mark for months already knows how their skin tends to respond, and that history is a useful clue.

Hypopigmentation: the pigment loss that may not come back

If dark patches are the frequent problem, pale ones are the feared one. Hypopigmentation is a loss of normal skin color, and after thermal injury it happens when melanocytes are destroyed rather than merely irritated. MedlinePlus groups these conditions under skin pigmentation disorders and notes that pigment loss from injury or burns may be temporary or permanent depending on how deeply the cells were affected.

The pattern after fibroblast treatment is recognizable. Each dot heals as a tiny pale disc, sometimes with a faintly glossy or waxy texture, and because the dots were placed in a grid, the result can look like a stippled or lattice pattern that becomes obvious under bright light or after a tan, when surrounding skin darkens and the treated spots do not. On the upper eyelid this can read as a chalky band. On the neck or upper lip it can look like scattered white freckles.

Unlike PIH, which often improves as melanin is gradually cleared, hypopigmentation from cell loss has no built-in mechanism for recovery. Melanocytes migrate slowly from the edges of a wound and from hair follicles, so very small, shallow dots may repigment over many months. Larger or deeper burns frequently do not. Dermatologists have limited tools for restoring lost pigment, and none that reliably reverse a grid of thermal scars.

This is why depth control matters so much, and why the risk climbs sharply when a practitioner performs a second or third session over the same area before the first has fully matured. A dot placed on top of an earlier, still-healing dot delivers heat to tissue that is already fragile. The Mayo Clinic’s guidance on ablative resurfacing lists permanent lightening of the skin among the recognized complications of aggressive treatment, and the same biology applies here, with less precision in the tool.

Plasma fibroblast scarring: pitting, keloids and texture change

A scar is what the body builds when a wound extends beyond the epidermis into the dermis. The NHS explains that scars form as part of normal healing and can take up to two years to settle and fade, and that some people are prone to raised scars regardless of how carefully a wound is managed. After fibroblast treatment, scarring takes a few characteristic forms.

The first is pitting: small depressed marks where a dot went too deep and the dermis healed with a slight dip. Under makeup these are subtle; in side light they can be obvious, and on thin eyelid skin they may crinkle when the eye closes. The second is textural change, a patch of skin that feels smoother or firmer than its neighbors, sometimes described as “plastic-like,” which reflects collagen laid down in a disorganized way rather than in the skin’s normal pattern.

The third, and most consequential, is hypertrophic or keloid scarring. A hypertrophic scar is raised but stays within the original wound edges. A keloid grows beyond them, sometimes continuing for months, and can be itchy or tender. The Cleveland Clinic notes that keloids are more likely in people with darker skin, in those with a personal or family history of keloids, and on certain body areas including the jawline, neck, chest and shoulders. Several of those sites overlap with places where plasma pens are marketed for tightening.

Scarring risk also rises with infection, with picking at crusts, and with repeated treatments in quick succession. Because the injury is thermal, the surrounding tissue is already inflamed, so an infected dot has a head start toward a lasting mark. Once a keloid forms, treatment is a specialist matter and outcomes are variable; the practical goal is to identify people at risk before the first session rather than after.

Fibroblast therapy on dark skin: which skin types are at higher risk

Skin tone is the single most important variable in fibroblast treatment risks, and it is the one most often glossed over in promotional material. Clinicians describe tone using the Fitzpatrick scale, a six-point classification based on how skin responds to sun: type I always burns and never tans, type VI never burns and is deeply pigmented. The scale is a rough proxy for melanocyte activity, which is what determines how skin reacts to heat.

People with Fitzpatrick types IV through VI, which includes many people of South Asian, East Asian, Middle Eastern, Hispanic, Indigenous and African heritage, have melanocytes that respond vigorously to inflammation. That makes post-inflammatory hyperpigmentation both more likely and longer lasting. The same groups carry a higher risk of keloids, as the Cleveland Clinic’s keloid guidance describes. And when melanocytes are destroyed rather than stimulated, the contrast between a pale dot and the surrounding skin is far more visible in deeper tones than in fair skin.

Types III, the olive or light-brown skin that tans easily, sit in an uncomfortable middle ground. Many people in this group are told they are “fine” for plasma treatment, yet they develop PIH readily, especially around the mouth and eyes.

Fitzpatrick type	Typical response to sun	Main heat-related concern
I–II	Burns easily, tans little	Redness, pale dots if too deep
III	Sometimes burns, tans gradually	PIH fairly common, usually fades
IV	Rarely burns, tans well	PIH common and persistent
V–VI	Very rarely burns, deeply pigmented	PIH, permanent light spots, keloids

A responsible practitioner will classify your skin before discussing treatment, ask about how past cuts, spots and burns healed, and may decline to treat or suggest a small test patch in a hidden area first. That caution is not gatekeeping. It reflects what the biology of pigmented skin does under heat.

Who fibroblast treatment is usually considered for, and who is asked to wait

In practice the people most likely to be offered plasma pen treatment are adults with fair to light-olive skin, mild to moderate laxity in a small area such as the upper eyelids or upper lip, no history of abnormal scarring, and realistic expectations. The treatment addresses surface tightening and fine lines. It does not lift sagging tissue, remove fat pads, or replace what a surgical blepharoplasty (eyelid surgery) or a face lift does, and a practitioner who implies otherwise is overselling.

A longer list describes who is usually asked to wait or advised against it altogether. The NHS guidance on cosmetic procedures stresses that any practitioner should take a full medical history and explain risks specific to the individual. Common reasons for caution include:

• Fitzpatrick skin types IV to VI, because of pigment and keloid risk.
• A personal or family history of keloids or hypertrophic scars.
• Active skin infection, cold sores, eczema, psoriasis or acne in the treatment area.
• Pregnancy or breastfeeding, where safety data are absent.
• Recent sunburn or a fresh tan, which signals stimulated melanocytes.
• Recent use of oral retinoids, which affect wound healing; the prescribing clinician should advise on timing.
• A pacemaker or other implanted electrical device, because of the electrical arc.
• Bleeding disorders or medicines that impair clotting, again a matter for the prescriber.
• Autoimmune conditions or medicines that suppress immunity, which slow healing.

People with a history of vitiligo, a condition in which pigment cells are lost in patches, deserve a separate mention: skin trauma can trigger new patches at the injury site, a phenomenon dermatologists call the Koebner response. A plasma grid is precisely that kind of trauma.

None of these are absolute bars imposed by a rulebook. They are the reasons a clinician will weigh before advising, and the decision about whether to proceed should sit with that clinician and the person whose face it is, not with a booking page.

Infection, eye injury and other complications people rarely hear about

Pigment and scarring dominate the conversation, but they are not the only fibroblast treatment risks. Each dot is an open wound for several days, and a grid of two hundred dots is two hundred small entry points for bacteria. Skin infection shows as spreading redness, warmth, increasing pain, yellow discharge or crusts that turn honey-colored. Because the surrounding skin is already inflamed from heat, infection can be hard to distinguish from normal healing at first glance, which is one reason a trained eye at follow-up matters.

The eye area brings its own hazards. The upper eyelid is the most popular treatment site, and it sits a few millimeters from the cornea. An arc that strays, a splash of the wound fluid, or heavy swelling that prevents the eye from closing properly can all lead to corneal irritation. Practitioners with medical training use protective eye shields; not all providers do. Anyone experiencing eye pain, light sensitivity or blurred vision after treatment needs urgent assessment.

Cold sore reactivation is another frequent surprise. The herpes simplex virus that causes cold sores lives in nerve tissue and is roused by skin injury and stress. Treatment around the mouth in someone with a history of cold sores can trigger an outbreak across the treated area, and a viral infection on top of fresh burns raises scarring risk. Physicians who perform laser resurfacing often prescribe preventive antiviral medicine for this reason; the Mayo Clinic lists herpes flare-ups among the recognized complications of ablative procedures. Whether that applies to you is a conversation for a prescriber.

Prolonged swelling, especially on the eyelids, can last longer than the advertised few days. Persistent redness, a burning sensation that outlasts healing, and milia (tiny white cysts that form as new skin traps keratin) are also reported. Most of these settle. A few, particularly nerve-related burning or numbness in the treated field, can linger for months and should be assessed rather than waited out.

Microneedling vs fibroblast vs CO2 laser: how the risks compare

Two of the most searched questions are whether microneedling or fibroblast is better, and whether CO2 laser or fibroblast is better. “Better” depends entirely on the goal, the skin type and who is doing it, so a more useful frame is how each approach injures the skin and what that means for risk.

Microneedling uses fine needles to make controlled punctures without heat. Because there is no thermal component, the pigment risk is lower, which is why it is more often offered across a wider range of skin tones. Its tightening effect is modest. Ablative CO2 laser resurfacing removes the epidermis with precisely metered light energy and is the most powerful of the three, with correspondingly higher risk and longer recovery; the Mayo Clinic notes that healing after ablative resurfacing typically takes one to two weeks, and that lightening of the skin and scarring are recognized complications, particularly in darker skin. Fractional and non-ablative laser variants reduce these risks at the cost of subtler results. Plasma pens sit somewhere between, using heat like a laser but with far less precise energy delivery.

Feature	Microneedling	Plasma fibroblast pen	Ablative CO2 laser
Mechanism	Mechanical punctures	Electrical arc, thermal dots	Metered light, removes surface
Heat involved	No (unless radiofrequency added)	Yes, variable	Yes, controlled
Pigment risk in deeper skin tones	Lower	High	High
Depth control	Set needle length	Operator dependent	Device metered
Typical operator	Varies widely	Varies widely, often non-medical	Usually physician-led
Evidence base	Moderate	Limited, small series	Extensive

The table is not a ranking. Microneedling is not “safer” if what you want is meaningful eyelid tightening, because it may not deliver it. A CO2 laser is not “better” if you have type V skin and a keloid history. The point is that the risks scale with heat and depth, and a plasma pen combines heat with the least predictable depth of the three. A dermatologist or plastic surgeon can match the tool to the skin rather than the other way round.

How long does fibroblasting last, and is plasma fibroblast worth it?

Marketing often quotes durations of two, three or even five years. It is worth being blunt about where those numbers come from: mostly from device sellers and training academies, not from controlled research. The published evidence on plasma skin regeneration consists largely of small case series and observational reports, and it does not support a firm figure for how long any improvement persists. Skin continues to age after any procedure, and the collagen laid down during healing is subject to the same sun, gravity and time as the rest of the face.

What can be said with more confidence is what happens in the near term. The immediate tightening seen on the day is partly swelling and heat contraction, and it softens as swelling resolves. Any collagen remodeling follows the general timeline of wound maturation, which the NHS describes as continuing for many months and, for scars, up to two years. So the appearance at six weeks is not the final result, in either direction: some tightening may develop later, and some pigment problems may also emerge later.

Is it worth it? That is a personal calculation that no article can make, but it can be framed honestly. On one side sits a possible modest improvement in fine lines and laxity in a small area, with no incision. On the other sits a real, skin-type-dependent risk of pigment change that may take a year to fade or may never fade, a smaller risk of pitted or raised scars, a week or more of visible crusting, and an evidence base thinner than for either microneedling or medical laser resurfacing.

For someone with fair skin, a small target area, an experienced medical practitioner and a genuine tolerance for the possibility of a poor outcome, the balance may look reasonable. For someone with medium or deep skin, or a history of dark marks after every blemish, the same balance looks quite different. Writing down what you would accept losing, not just what you hope to gain, is a more honest way to decide.

What the days and weeks after fibroblast treatment usually look like

Healing is not a single event. It runs in overlapping phases, and knowing what belongs to each phase helps you tell ordinary recovery from a problem. The timelines below describe common experiences and align with the general pattern the Mayo Clinic outlines for ablative skin procedures; individual recovery varies, and only your practitioner can judge whether your skin is on track.

The first hours. The treated area is red, hot and stinging, much like a fresh sunburn. Each dot is a small dark point. Swelling begins within hours and is often most dramatic on the eyelids, where fluid pools easily. Some people find their eyes swollen nearly shut the next morning; this is alarming but commonly reported.

Days one to three. Swelling usually peaks and then starts to ease. The dots darken and form firm crusts. The skin may weep a little clear fluid. Practitioners typically advise keeping the area clean and dry, avoiding makeup, and not touching or picking. Sleeping with the head raised helps eyelid swelling drain.

Days four to ten. Crusts loosen and fall off on their own. Underneath, the new skin is pink and tender. This is the moment picking does the most damage, because pulling a crust early removes the fragile epidermis beneath and deepens the wound. Strict sun avoidance matters from now on, and most practitioners recommend a broad-spectrum sunscreen once the skin has closed.

Weeks two to six. The pink fades. This is also the window in which post-inflammatory hyperpigmentation tends to appear, and when the difference between a dot that healed well and one that went too deep becomes visible.

Months two to twelve. Collagen remodeling continues. Pigment changes may improve, stay the same, or become more obvious against a summer tan. Any texture change or pitting declares itself. A follow-up examination during this period is more informative than any photo taken at week one.

What people often get wrong about fibroblast treatment risks

Misunderstandings cluster around a handful of claims, and correcting them is more useful than repeating warnings.

“It’s non-invasive, so it’s low risk.” Non-invasive usually means no incision, and that is true here. It does not mean no injury. A plasma pen creates hundreds of small burns. Burns scar and change pigment; that is what they do.

“The brown dots are the treatment working.” The dots are carbonized skin and crust. They are evidence of injury, not of collagen production. Collagen remodeling happens weeks later and is invisible.

“Darker skin just needs a lower setting.” Lower energy reduces depth but does not remove the thermal trigger for melanin, and it does not change a person’s underlying tendency to form keloids. The Cleveland Clinic’s guidance on hyperpigmentation and keloids describes both as more common in deeper skin tones regardless of the size of the injury.

“More sessions mean better results.” Repeat treatments over the same area, particularly before the earlier wounds have matured, stack heat on already fragile tissue and are a recognized route to permanent light spots and pitting.

“If it goes wrong, a laser can fix it.” Some pigment problems respond to prescription lightening agents or gentle resurfacing under a dermatologist’s care. Pigment loss from destroyed melanocytes usually does not, and keloids are difficult to treat by any method. Prevention through skin assessment is the realistic strategy.

“It’s the same as what dermatologists call plasma skin regeneration.” Early medical plasma devices were studied in clinical settings with metered energy. Many handheld pens sold today are different tools operated by people with very different training. The shared word “plasma” is doing a lot of work in that comparison.

“Downtime is a couple of days.” Crusting commonly lasts a week or more, and redness or pinkness can persist for weeks. Planning around a two-day recovery is a frequent source of regret.

Questions to ask your care team before agreeing to fibroblast treatment

The NHS advice on cosmetic procedures recommends a consultation in which the practitioner takes a medical history, explains the specific risks for you, and gives you time to think before booking. The questions below are designed to make that conversation concrete. Note who answers them and how comfortably.

• What is my Fitzpatrick skin type, and how does that change my risk of dark patches, light spots and keloids with this device?
• What is your medical training, and who supervises you? What happens if I develop an infection or a scar; who will I see, and where?
• Will you do a test patch in a hidden area first, and how long will we wait to assess it before treating my face?
• How many of your patients with skin like mine have developed pigment changes, and may I see their healed photos at six months rather than at one week?
• How do you protect the eye if you are treating my eyelids?
• I have a history of cold sores, dark marks after acne, or a raised scar; how does that change your advice?
• What exactly should I expect on each of the first ten days, and what would make you want to see me urgently?
• How many sessions are you proposing, how far apart, and why is a second session needed if the first has not fully matured?
• What are the alternatives for my concern, including doing nothing, and what would a dermatologist or plastic surgeon offer for the same problem?
• Is this device regulated for use on skin in this country, and who is legally responsible if something goes wrong?

Any answer that leans on “everyone heals fine” or that shows only day-seven photos deserves gentle pushback. A practitioner who volunteers the risks, suggests a patch test, and is willing to say no is demonstrating the judgment that separates a safe procedure from a gamble. The decision to proceed remains yours, made with a clinician who has examined your skin and knows your history, and that decision can always be to wait.

When to call your doctor after fibroblast treatment

Most people who have plasma pen treatment experience redness, swelling, stinging and crusting that settle over a week or two without medical help. Some signs, though, point to complications that need prompt assessment. If you notice any of the following, contact your treating practitioner or a doctor the same day, and do not wait for a scheduled follow-up.

• Spreading redness beyond the treated area, increasing warmth, throbbing pain that worsens after day two, or yellow-green discharge. These suggest infection, and untreated infection deepens wounds and raises scarring risk.
• Fever, chills or feeling generally unwell in the days after treatment.
• Eye pain, light sensitivity, blurred vision, a gritty sensation, or an eyelid so swollen that the eye cannot close fully. Corneal injury needs urgent care, and an eye that stays partly open while sleeping can dry and ulcerate.
• Clusters of small fluid-filled blisters, especially around the mouth or nose, which may indicate a cold sore outbreak spreading across fresh wounds.
• A wound that is still open, weeping or crusted beyond two weeks, or that reopens after appearing to heal.
• Any area becoming raised, firm, itchy or growing beyond the original dots in the weeks or months afterward, which can be an early keloid and is easier to manage when caught early.
• Dark or pale patches that are still clearly visible at three months, so a dermatologist can assess whether treatment might help and rule out other causes.
• Persistent numbness, burning or altered sensation in the treated field.

Seek emergency care for severe facial swelling with difficulty breathing or swallowing, or sudden vision loss. These are rare but are not situations for waiting on a message reply.

Keep dated photos of your healing so a clinician can compare. And if the person who treated you is not medically qualified or cannot be reached, a primary care doctor, urgent care service or dermatologist is the right next call. Bring the name of the device and the settings used if you have them.

Frequently asked questions

Which is better, microneedling or fibroblast?

Neither is universally better; they injure skin differently and suit different people. Microneedling uses needles without heat, so it carries lower pigment risk and is more often used across skin tones, but its tightening effect is modest. Plasma fibroblast uses thermal energy, which may tighten small areas more but raises the odds of dark or light patches, especially in deeper skin. A dermatologist can match the tool to your skin type and goal.

Which is better, CO2 laser or fibroblast?

An ablative CO2 laser delivers more controlled, metered energy and has a far larger evidence base, but it is also more powerful, with the Mayo Clinic noting one to two weeks of healing and recognized risks of pigment change and scarring. Plasma pens use less energy with less precise depth control and are often operated by non-medical providers. Both are heat-based, so both carry pigment risk in darker skin; the choice belongs with a qualified clinician.

How long does fibroblasting last?

There is no reliable figure. Claims of two to five years come mainly from device sellers rather than controlled research, which consists largely of small observational reports. Any collagen remodeling follows the general course of wound maturation, which the NHS describes as continuing for many months and up to two years for scars, and skin keeps aging afterward. Treat any specific duration promise as unproven.

Is plasma fibroblast worth it?

That depends on your skin type, the area, your tolerance for a poor outcome and who performs it. For fair skin, a small target and an experienced medical practitioner, some people judge the trade-off acceptable. For medium or deep skin tones, or anyone with a history of dark marks or raised scars, the risk of lasting pigment change or scarring often outweighs a modest, unproven benefit. A clinician’s assessment should inform the decision.

What are the most common plasma pen side effects?

Redness, swelling, stinging and a grid of dark crusts for about a week are expected. The most common lasting problem is post-inflammatory hyperpigmentation, dark patches that appear once crusts fall off and can persist for months. Less common but more serious are pale spots from pigment loss, small pitted scars, raised or keloid scars, infection, cold sore outbreaks and eye irritation when the eyelids are treated.

Is fibroblast therapy safe on dark skin?

It carries substantially higher risk. Skin with more active melanocytes responds to heat by overproducing melanin, so post-inflammatory hyperpigmentation is more likely and longer lasting, and the Cleveland Clinic notes keloids are more common in darker skin. When melanocytes are destroyed, pale dots stand out sharply against deeper tones. Many dermatologists advise against heat-based devices in Fitzpatrick types IV to VI or insist on a patch test first.

Can plasma fibroblast scarring be reversed?

Some texture changes soften as scars mature over months, and a dermatologist may offer options for pitted or raised scars, though results vary and keloids are notoriously difficult to manage. Pigment loss from destroyed pigment cells rarely returns. Because reversal is unreliable, the realistic strategy is prevention: proper skin assessment, conservative depth, a test patch and avoiding repeat sessions before earlier wounds have matured.

How long does hyperpigmentation last after fibroblast treatment?

It varies with skin type, depth of the burn and sun exposure. The Cleveland Clinic notes post-inflammatory hyperpigmentation can fade on its own over months but may persist a year or longer, particularly when pigment sits deeper in the skin. Strict sun protection during healing reduces the risk of it darkening further. If patches remain clearly visible at three months, a dermatologist can assess whether treatment might help.

Can I have fibroblast treatment if I get cold sores?

It needs discussion with a prescriber first. Skin injury can reactivate the herpes simplex virus, and an outbreak across fresh burns raises scarring risk. Physicians performing laser resurfacing often prescribe preventive antiviral medicine for people with a cold sore history, and the Mayo Clinic lists herpes flare-ups among recognized complications of ablative procedures. Whether that applies to you is a decision for your clinician, not the person selling the treatment.

What should I do if my eyelids swell shut after plasma pen treatment?

Marked eyelid swelling in the first two days is commonly reported and usually eases with the head raised. Seek same-day medical assessment if you have eye pain, light sensitivity, blurred vision, a gritty feeling, or if the eye cannot close fully, because an exposed cornea can dry and ulcerate. Spreading redness, discharge or fever alongside swelling suggests infection and also needs prompt care.

References

• Cleveland Clinic: Hyperpigmentation
• MedlinePlus: Skin Pigmentation Disorders
• NHS: Scars
• NHS: Cosmetic procedures

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.